Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on ...
The Swedish drugmaker has come up short in its effort to push imlifidase into treatment of the autoimmune condition ...
Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...
A groundbreaking discovery offers hope for reversing kidney damage, challenging the notion that it's irreversible.
TipRanks on MSN
Exelixis and Merck advance LITESPARK-033: A new kidney cancer combo with high-stakes market potential
Exelixis ($EXEL) announced an update on their ongoing clinical study. Study Overview The LITESPARK-033 study, formally titled “A Phase 3, ...
PKD is mainly caused by mutations in the PKD1 and PKD2 genes, affecting polycystin proteins. Disrupted signaling pathways, like cAMP and vasopressin, are major drivers of cyst growth. Tolvaptan is ...
Researchers at the Perelman School of Medicine identified over 1,000 genes that could serve as potential treatment targets for kidney disease in a newly published study. The study marks the most ...
University of Virginia School of Medicine scientists have obtained important new insights into how our bodies regulate our blood pressure by revealing how our cells turn off a key hormone. The ...
In a new study, researchers examined the Renal Activity Index for Lupus (RAIL) diagnostic tool to assess its success for ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
Since 2017, there is no shortage of funds for healthcare services in Uttar Pradesh, says chief minister Yogi Adityanath ...
Scarring is a key feature of chronic kidney disease. Now, University of Connecticut researchers report in Kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results